The Role of Metformin Response in Lipid Metabolism in Patients with Recent-Onset Type 2 Diabetes: HbA1c Level as a Criterion for Designating Patients as Responders or Nonresponders to Metformin

The variant organic cation transporter 2 (OCT2)–T201M contribute to changes in insulin resistance in patients with type 2 diabetes treated with metformin

(2015) Zahra Kashi et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis

(2012) Hiroshi Noto et al.   PLoS One

Disposition of metformin: Variability due to polymorphisms of organic cation transporters

(2011) Oliver Zolk   ANNALS OF MEDICINE

Treating Mixed Hyperlipidemia and the Atherogenic Lipid Phenotype for Prevention of Cardiovascular Events

(2010) Melvyn Rubenfire et al.   AMERICAN JOURNAL OF MEDICINE

Mechanisms of metformin action on glucose transport and metabolism in human adipocytes

(2010) Jean Grisouard et al.   BIOCHEMICAL PHARMACOLOGY

Racial differences in the association between body fat distribution and lipid profiles among reproductive-age women

(2010) G.M.M. Hosain et al.   DIABETES & METABOLISM

The Effect of Oral Antidiabetic Agents on A1C Levels: A systematic review and meta-analysis

(2010) D. Sherifali et al.   DIABETES CARE

Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Metformin - the gold standard in type 2 diabetes: what does the evidence tell us?

(2009) E. Bosi   DIABETES OBESITY & METABOLISM

Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver

(2009) Anne T. Nies et al.   HEPATOLOGY

Polymorphism in human organic cation transporters and metformin action

(2008) Hiroshi Takane et al.   PHARMACOGENOMICS